How One Cardiothoracic Surgeon Creates Positive Patient Relationships

As it pertains to doctor-patient relationships, one of the main components of that is confidentiality and professionalism. But another key aspect to successful relationships between a doctor and their patient is also how successful the communication is and whether the doctor is building good rapport with them.

What are some fundamentals of positive patient relationships?

On an episode of the I Don’t Care podcast, host Kevin Stevenson interviewed Dr. Mark Pool, a Cardiothoracic Surgeon at Texas Health Physicians Group, about his perspective on how doctors can improve their patient relationships and form stronger bonds through better communication.

Dismissive or nonchalant attitudes from doctors lead to disparities in healthcare. But if doctors display certain traits, such as active listening, research shows that it will build more trust and improve patient relationships. Dr. Pool added that his own experience as a patient has allowed him to see where doctors can get it wrong.

“As a patient that I’ve gone to see a physician and I’m sitting there in the exam room and the doctor walks in, doesn’t look at me, looking down on at something and says, ‘I see you’re here for X,’ and it’s just always on my mind because I know it can be done better than that, and I think it just starts with the basics of building rapport,” said Pool.

Stevenson and Pool also explored…

  1. The types of traits doctors should possess to encourage patients to be more open with them
  2. Tips and communication styles on interacting with patients and their relatives
  3. Preferred wording and verbiage to use when discussing health issues with patients

Pool added that in his specialty, heart-care patients already have a sense of fear when it comes to their health, so specific wording is important when talking with them.

“Constant attention in being careful with the wording helps disarm it,” he said. “…Carefully word it where it’s a little less intimidating and make them feel like I’m on their side. ‘I’m here for you, we are going to get through this together.’ Those are the kind of words that I think patients respond to, and it’s not fake — it’s not a show, it’s just me intentionally doing it that way so that patients will have less fear, they’ll have less anxiety.”

Dr. Mark Pool is a board-certified Cardiothoracic Surgeon at Texas Health Physicians Group. His work in the medical field also focuses on shifting and changing the way medical professionals communicate with their patients. Pool has been named Super Doctor and Rising Star by Texas Monthly, and was named Best Doctor in D Magazine. He is a graduate of the University of Texas Southwestern Medical School in Dallas.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More